About Products

Our high potency brain health formula “neurotopia” contains scallop-derived plasmalogen extracted using a unique extraction technology developed by university researchers and scientists in Japan

  • Supports Healthy Cognitive Function
  • Improves Memory & Mental Clarity
  • Delays Brain Deterioration
Supplement

NAME OF FINISHED PRODUCT

PRODUCT NAME

NEUROTOPIA （ PLASMALOGEN BOOCS )

GENERAL NAME

Scallop E xtract - Containing Processed F ood

CLASSIFICATION

Food

R AW MATERIAL

scallop extract (Japanese), starch decomposition product, HPMC, γ - cyclodextrin

PACKAGING

CONTENTT

mg/capsule

QUANTITY

capsules

DIMENSION, MATERIAL

W67 x H130 x D34 (mm) , Paper

BEST - BEFORE DATE

3 years from the date of manufacture (unopened). Consume immediately once opened

STORAGE CONDITIONS

Store in a cool, dry place away from direct sunlight

QUALITY SPECIFICATION AND INSPECTION REPORT

ITEM

STANDARD VALUES

ANALISIS METHODS

INSPECTION

RESULTS

ASPECT

Transparent hard - type capsule filled with white powder. No breaking or cracking

visual inspection

total inspection

adequate

FUNCTIONAL SUBSTANCE (ETHER PHOSPHOLIPID)

Plasmalogen ≥ 1.0 mg/capsule

high - performance liquid chromatography

lot inspection

≥ 1.0 mg/capsule

CAPSULE WEIGHT

240 ± 15mg

weight measurement

lot inspection

240 ±15mg

AEROBIC PLATE COUNT

≤ 3000/g

standard agar medium method

lot inspection

≤300/ g

COLIFORM BACTERIA

negative

desoxycholate agar medium method

lot inspection

negative

QUALITY SPECIFICATION AND INSPECTION REPORT

ITEM

ASPECT

FUNCTIONAL SUBSTANCE (ETHER PHOSPHOLIPID)

CAPSULE WEIGHT

AEROBIC PLATE COUNT

COLIFORM BACTERIA

STANDARD VALUES

Transparent hard - type capsule filled with white powder. No breaking or cracking

Plasmalogen ≥ 1.0 mg/capsule

240 ± 15mg

≤ 3000/g

negative

ANALISIS METHODS

visual inspection

high - performance liquid chromatography

weight measurement

standard agar medium method

desoxycholate agar medium method

INSPECTION

total inspection

lot inspection

lot inspection

lot inspection

lot inspection

RESULTS

adequate

≥ 1.0 mg/capsule

240 ±15mg

≤300/ g

negative